List Name |
Annotation |
Enrichment |
p-value |
di-, tri-valent inorganic cation homeostasis |
AmiGO Browser |
9.28 |
2.34e-04 |
metal ion homeostasis |
AmiGO Browser |
8.95 |
2.76e-04 |
transition metal ion homeostasis |
AmiGO Browser |
22.07 |
3.60e-04 |
cation homeostasis |
AmiGO Browser |
8.29 |
3.91e-04 |
cell ion homeostasis |
AmiGO Browser |
7.87 |
4.95e-04 |
amino acid transport |
AmiGO Browser |
19.57 |
5.12e-04 |
ion homeostasis |
AmiGO Browser |
7.44 |
6.39e-04 |
neutral amino acid transport |
AmiGO Browser |
42.58 |
1.02e-03 |
amine transport |
AmiGO Browser |
15.36 |
1.04e-03 |
mesoderm development |
AmiGO Browser |
14.80 |
1.16e-03 |
response to metal ion |
AmiGO Browser |
38.53 |
1.24e-03 |
chemical homeostasis |
AmiGO Browser |
6.26 |
1.37e-03 |
organic acid transport |
AmiGO Browser |
12.51 |
1.87e-03 |
carboxylic acid transport |
AmiGO Browser |
12.51 |
1.87e-03 |
response to inorganic substance |
AmiGO Browser |
29.97 |
2.06e-03 |
cell homeostasis |
AmiGO Browser |
5.57 |
2.27e-03 |
homeostatic process |
AmiGO Browser |
4.09 |
8.28e-03 |
transition metal ion transport |
AmiGO Browser |
12.26 |
0.01 |
organ development |
AmiGO Browser |
2.33 |
0.01 |
in utero embryonic development |
AmiGO Browser |
11.56 |
0.01 |
embryonic development |
AmiGO Browser |
4.08 |
0.02 |
response to chemical stimulus |
AmiGO Browser |
3.35 |
0.02 |
regulation of biological quality |
AmiGO Browser |
2.92 |
0.02 |
regulation of interleukin-6 biosynthetic process |
AmiGO Browser |
50.57 |
0.02 |
multicellular organismal development |
AmiGO Browser |
1.87 |
0.02 |
mesodermal cell differentiation |
AmiGO Browser |
44.95 |
0.02 |
mesodermal cell fate commitment |
AmiGO Browser |
44.95 |
0.02 |
regulation of Rho GTPase activity |
AmiGO Browser |
44.95 |
0.02 |
negative regulation of small GTPase mediated signal transduction |
AmiGO Browser |
44.95 |
0.02 |
positive regulation of B cell proliferation |
AmiGO Browser |
40.45 |
0.02 |
copper ion homeostasis |
AmiGO Browser |
40.45 |
0.02 |
interleukin-6 biosynthetic process |
AmiGO Browser |
40.45 |
0.02 |
interleukin-6 production |
AmiGO Browser |
40.45 |
0.02 |
muscle development |
AmiGO Browser |
4.74 |
0.03 |
zinc ion transport |
AmiGO Browser |
36.78 |
0.03 |
negative regulation of cell-cell adhesion |
AmiGO Browser |
36.78 |
0.03 |
negative regulation of B cell activation |
AmiGO Browser |
36.78 |
0.03 |
regulation of transcription from RNA polymerase III promoter |
AmiGO Browser |
36.78 |
0.03 |
regulation of cell-matrix adhesion |
AmiGO Browser |
33.71 |
0.03 |
placenta development |
AmiGO Browser |
33.71 |
0.03 |
sulfate transport |
AmiGO Browser |
33.71 |
0.03 |
cell fate commitment |
AmiGO Browser |
7.29 |
0.03 |
galactose metabolic process |
AmiGO Browser |
31.12 |
0.03 |
regulation of cell-cell adhesion |
AmiGO Browser |
31.12 |
0.03 |
aspartate family amino acid biosynthetic process |
AmiGO Browser |
31.12 |
0.03 |
regulation of T-helper cell differentiation |
AmiGO Browser |
31.12 |
0.03 |
morphogenesis of an epithelium |
AmiGO Browser |
7.16 |
0.03 |
neuromuscular synaptic transmission |
AmiGO Browser |
28.90 |
0.03 |
regulation of production of molecular mediator of immune response |
AmiGO Browser |
28.90 |
0.03 |
cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
gut development |
AmiGO Browser |
28.90 |
0.03 |
regulation of cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
system development |
AmiGO Browser |
1.88 |
0.04 |
oligosaccharide biosynthetic process |
AmiGO Browser |
26.97 |
0.04 |
response to virus |
AmiGO Browser |
6.52 |
0.04 |
regulation of chemotaxis |
AmiGO Browser |
25.28 |
0.04 |
L-amino acid transport |
AmiGO Browser |
25.28 |
0.04 |
regulation of B cell proliferation |
AmiGO Browser |
25.28 |
0.04 |
L-fucose catabolic process |
AmiGO Browser |
23.80 |
0.04 |
fucose catabolic process |
AmiGO Browser |
23.80 |
0.04 |
alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
specification of organ identity |
AmiGO Browser |
23.80 |
0.04 |
cell-cell signaling during cell fate commitment |
AmiGO Browser |
23.80 |
0.04 |
induction of an organ |
AmiGO Browser |
23.80 |
0.04 |
induction |
AmiGO Browser |
23.80 |
0.04 |
T cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
leukocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
lymphocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
polyamine metabolic process |
AmiGO Browser |
23.80 |
0.04 |
T-helper cell differentiation |
AmiGO Browser |
23.80 |
0.04 |
response to external stimulus |
AmiGO Browser |
2.66 |
0.04 |
regulation of isotype switching |
AmiGO Browser |
22.47 |
0.04 |
chordate embryonic development |
AmiGO Browser |
5.95 |
0.05 |
embryonic development ending in birth or egg hatching |
AmiGO Browser |
5.91 |
0.05 |
eye photoreceptor cell differentiation |
AmiGO Browser |
21.29 |
0.05 |
eye photoreceptor cell development |
AmiGO Browser |
21.29 |
0.05 |
dicarboxylic acid transport |
AmiGO Browser |
21.29 |
0.05 |
CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
21.29 |
0.05 |
negative regulation of immune response |
AmiGO Browser |
20.23 |
0.05 |
negative regulation of immune system process |
AmiGO Browser |
20.23 |
0.05 |
T-helper 2 type immune response |
AmiGO Browser |
20.23 |
0.05 |
photoreceptor cell development |
AmiGO Browser |
20.23 |
0.05 |
regulation of immune effector process |
AmiGO Browser |
20.23 |
0.05 |
photoreceptor cell differentiation |
AmiGO Browser |
20.23 |
0.05 |
biogenic amine catabolic process |
AmiGO Browser |
19.26 |
0.05 |
L-fucose metabolic process |
AmiGO Browser |
19.26 |
0.05 |
anatomical structure development |
AmiGO Browser |
1.72 |
0.05 |
Rho protein signal transduction |
AmiGO Browser |
5.39 |
0.05 |
tube development |
AmiGO Browser |
5.32 |
0.05 |
negative regulation of apoptosis |
AmiGO Browser |
3.52 |
0.06 |
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. |
AmiGO Browser |
17.59 |
0.06 |
regulation of T cell differentiation |
AmiGO Browser |
17.59 |
0.06 |
aspartate family amino acid metabolic process |
AmiGO Browser |
17.59 |
0.06 |
regulation of adaptive immune response |
AmiGO Browser |
17.59 |
0.06 |
neuron maturation |
AmiGO Browser |
17.59 |
0.06 |
cytokine production |
AmiGO Browser |
5.29 |
0.06 |
negative regulation of programmed cell death |
AmiGO Browser |
3.50 |
0.06 |
negative regulation of lyase activity |
AmiGO Browser |
16.86 |
0.06 |
negative regulation of cyclase activity |
AmiGO Browser |
16.86 |
0.06 |
negative regulation of adenylate cyclase activity |
AmiGO Browser |
16.86 |
0.06 |
DNA catabolic process |
AmiGO Browser |
16.86 |
0.06 |
catabolic process |
AmiGO Browser |
2.43 |
0.06 |
immune response |
AmiGO Browser |
2.41 |
0.06 |
glutamine metabolic process |
AmiGO Browser |
16.18 |
0.06 |
regulation of defense response |
AmiGO Browser |
16.18 |
0.06 |
regulation of inflammatory response |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of locomotion |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of B cell activation |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of epithelial cell proliferation |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of cell motility |
AmiGO Browser |
16.18 |
0.06 |
neural crest cell migration |
AmiGO Browser |
15.56 |
0.06 |
B cell proliferation |
AmiGO Browser |
14.98 |
0.06 |
amino acid derivative catabolic process |
AmiGO Browser |
14.98 |
0.06 |
fucose metabolic process |
AmiGO Browser |
14.98 |
0.06 |
calcium ion homeostasis |
AmiGO Browser |
4.79 |
0.07 |
alpha-beta T cell differentiation |
AmiGO Browser |
14.45 |
0.07 |
cell motility |
AmiGO Browser |
2.60 |
0.07 |
localization of cell |
AmiGO Browser |
2.60 |
0.07 |
inflammatory response |
AmiGO Browser |
3.17 |
0.07 |
vasculogenesis |
AmiGO Browser |
13.48 |
0.07 |
somatic recombination of immunoglobulin genes during immune response |
AmiGO Browser |
13.48 |
0.07 |
isotype switching |
AmiGO Browser |
13.48 |
0.07 |
somatic diversification of immunoglobulins during immune response |
AmiGO Browser |
13.48 |
0.07 |
response to nutrient |
AmiGO Browser |
13.48 |
0.07 |
immunoglobulin production during immune response |
AmiGO Browser |
13.48 |
0.07 |
regulation of lymphocyte differentiation |
AmiGO Browser |
13.48 |
0.07 |
taxis |
AmiGO Browser |
4.52 |
0.07 |
chemotaxis |
AmiGO Browser |
4.52 |
0.07 |
anatomical structure morphogenesis |
AmiGO Browser |
1.94 |
0.07 |
somatic cell DNA recombination |
AmiGO Browser |
13.05 |
0.07 |
prostaglandin metabolic process |
AmiGO Browser |
13.05 |
0.07 |
somatic diversification of immune receptors via germline recombination within a single locus |
AmiGO Browser |
13.05 |
0.07 |
prostanoid metabolic process |
AmiGO Browser |
13.05 |
0.07 |
somatic recombination of immunoglobulin gene segments |
AmiGO Browser |
13.05 |
0.07 |
fat cell differentiation |
AmiGO Browser |
13.05 |
0.07 |
cell-cell signaling |
AmiGO Browser |
2.25 |
0.07 |
regulation of response to stimulus |
AmiGO Browser |
12.64 |
0.08 |
multicellular organismal process |
AmiGO Browser |
1.50 |
0.08 |
oligosaccharide metabolic process |
AmiGO Browser |
12.26 |
0.08 |
eye morphogenesis |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell development |
AmiGO Browser |
12.26 |
0.08 |
peripheral nervous system development |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell differentiation |
AmiGO Browser |
12.26 |
0.08 |
response to other organism |
AmiGO Browser |
4.28 |
0.08 |
somatic diversification of immunoglobulins |
AmiGO Browser |
11.90 |
0.08 |
negative regulation of lymphocyte activation |
AmiGO Browser |
11.90 |
0.08 |
somatic diversification of immune receptors |
AmiGO Browser |
11.90 |
0.08 |
circadian rhythm |
AmiGO Browser |
11.90 |
0.08 |
regulation of epithelial cell proliferation |
AmiGO Browser |
11.56 |
0.08 |
embryonic epithelial tube formation |
AmiGO Browser |
11.56 |
0.08 |
ureteric bud development |
AmiGO Browser |
11.56 |
0.08 |
epithelial cell proliferation |
AmiGO Browser |
11.24 |
0.09 |
alpha-beta T cell activation |
AmiGO Browser |
11.24 |
0.09 |
cellular macromolecule catabolic process |
AmiGO Browser |
2.90 |
0.09 |
tissue development |
AmiGO Browser |
2.90 |
0.09 |
NLS-bearing substrate import into nucleus |
AmiGO Browser |
10.93 |
0.09 |
di-, tri-valent inorganic cation transport |
AmiGO Browser |
4.03 |
0.09 |
mesoderm formation |
AmiGO Browser |
10.65 |
0.09 |
regulation of B cell activation |
AmiGO Browser |
10.65 |
0.09 |
mesenchymal cell development |
AmiGO Browser |
10.65 |
0.09 |
negative regulation of cell adhesion |
AmiGO Browser |
10.65 |
0.09 |
regulation of cytokine production |
AmiGO Browser |
10.37 |
0.09 |
immunoglobulin production |
AmiGO Browser |
10.37 |
0.09 |
mesenchymal cell differentiation |
AmiGO Browser |
10.37 |
0.09 |
cellular catabolic process |
AmiGO Browser |
2.35 |
0.09 |
formation of primary germ layer |
AmiGO Browser |
10.11 |
0.09 |
mesoderm morphogenesis |
AmiGO Browser |
10.11 |
0.09 |
iron ion homeostasis |
AmiGO Browser |
10.11 |
0.09 |
metanephros development |
AmiGO Browser |
9.87 |
0.10 |
amino acid and derivative metabolic process |
AmiGO Browser |
2.76 |
0.10 |
behavior |
AmiGO Browser |
2.73 |
0.10 |
hexose metabolic process |
AmiGO Browser |
3.76 |
0.10 |
positive regulation of lymphocyte proliferation |
AmiGO Browser |
9.41 |
0.10 |
positive regulation of mononuclear cell proliferation |
AmiGO Browser |
9.41 |
0.10 |
response to nutrient levels |
AmiGO Browser |
9.41 |
0.10 |
feeding behavior |
AmiGO Browser |
9.41 |
0.10 |
response to hypoxia |
AmiGO Browser |
9.41 |
0.10 |
iron ion transport |
AmiGO Browser |
9.19 |
0.10 |
acute-phase response |
AmiGO Browser |
9.19 |
0.10 |
response to stimulus |
AmiGO Browser |
1.56 |
0.10 |
monosaccharide metabolic process |
AmiGO Browser |
3.68 |
0.10 |